19:58 , Sep 21, 2017 |  BC Innovations  |  Tools & Techniques

On your marks

With less fanfare than the first two waves, a quiet rise in activity is driving a revival of interest in epigenetics, despite little progress in solving the fundamental challenges that have dogged the field from...
20:15 , May 25, 2017 |  BC Innovations  |  Finance

Europe’s translational springtime

European science is showing early signs of translational growth, with VCs increasingly shifting their focus to preclinical assets. But investors are concerned the region still doesn’t have the supply of management talent or funding it...
02:10 , Feb 14, 2017 |  BioCentury  |  Emerging Company Profile

Divide or conquer

Argonaut Therapeutics Ltd. is attacking cancer by inhibiting an epigenetic regulatory protein that controls a dual role for the E2F1 pathway. By inhibiting the PRMT5 enzyme, the company’s molecules flip the pathway from growth and...
07:00 , Oct 24, 2016 |  BC Week In Review  |  Financial News

Argonaut Therapeutics completes venture financing

Argonaut Therapeutics Ltd. , Oxford, U.K.  Business: Cancer  Date completed: 2016-10-19  Type: Venture financing  Raised: Not disclosed  Investor: Oxford Sciences Innovation plc  Note: The amount raised is not disclosed. ...
07:00 , Aug 3, 2015 |  BioCentury  |  Finance

Taiwan's post-bubble prognosis

More than a year after BioCentury chronicled investor enthusiasm for biotechs in Taiwan, the bubble has deflated. It's tempting to blame the downturn simply on retail investors who didn't get up to speed as quickly...
07:00 , May 9, 2011 |  BC Week In Review  |  Financial News

Crown BioScience completes venture financing

Crown BioScience Inc. , Santa Clara, Calif.   Business: Supply/Service   Date completed: 5/4/11   Type: Venture financing   Raised: $28.8 million   Investors: OrbiMed Advisors Caduceus Asia Partners Fund; Argonaut Private Equity; CID Group;...
23:42 , May 4, 2011 |  BC Extra  |  Financial News

Crown raises $28.8 million

CRO Crown Biosciences Inc. (Santa Clara, Calif.) raised $28.8 million in a series C round led by OrbiMed Advisors Caduceus Asia Partners Fund; Argonaut Private Equity; CID Group; IBT; and CDIB Capital Investment. Existing shareholders...
07:00 , May 7, 2007 |  BC Week In Review  |  Company News

diaDexus management update

diaDexus Inc. , South San Francisco, Calif.   Business: Diagnostic   Hired: David Foster as CFO and EVP, formerly CFO of Argonaut Technologies Inc. ; and Dino Alfano as EVP of sales and marketing, formerly...
07:00 , Jul 31, 2006 |  BC Week In Review  |  Company News

TransPharma board of directors update

TransPharma Medical Ltd. , Lod, Israel   Business: Drug delivery   Appointed: Jason Martin, a managing director at Argonaut Private Equity  ...
02:12 , Jul 25, 2006 |  BC Extra  |  Financial News

TransPharma raises $18 million

TransPharma (Lod, Israel) raised $18 million in a series C round led by Argonaut . New investor Teva (TEVA) joined existing investors Pitango; Evergreen Partners; T2C2; Vitalife; Biomedical Investments; and TIF Ventures. TransPharma's transdermal hPTH...